Catalyst Biosciences Added to Russell 2000 Index
SOUTH SAN FRANCISCO, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), today announced that it has been added to the Russell 2000® Index effective at the U.S. market open today, June 29, 2020.
The Annual Russell index reconstitution captures the 4,000 largest US stocks as of May 8, ranking them by total market capitalization. Membership in the U.S. Russell 2000 Index® remains in place for one year and also means automatic inclusion in the appropriate growth and value style indices.
Russell indices are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell’s U.S. indices. Russell indices are part of FTSE Russell, a leading global index provider.
For more information on the Russell 2000 and the Russell index reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.
About Catalyst Biosciences